Johns Hopkins Researchers Identify Cysteine as Dual Fuel Source Regulating T Cell Proliferation and Cancer Killing Capabilities

Johns Hopkins scientists discover how cysteine metabolism controls the balance between T cell growth and cancer-killing power in new immunotherapy research.

By: AXL Media

Published: Apr 1, 2026, 5:46 AM EDT

Source: Information for this report was sourced from Johns Hopkins Medicine

Metabolic Resource Management in Immune Defense

New findings from the Johns Hopkins Kimmel Cancer Center have uncovered a sophisticated resource management system within the immune system’s primary frontline defenders. Researchers discovered that CD8+ T cells rely on a single nutrient, the amino acid cysteine, to power two competing biological requirements, the ability to rapidly multiply and the capacity to effectively neutralize malignant cells. According to senior author Erika Pearce, a Bloomberg Distinguished Professor at Johns Hopkins, the internal supply of cysteine is essentially split between these two pathways, meaning the cell must prioritize its metabolic "spending" to determine its overall behavior in the presence of a tumor.

The Bifurcation of Cysteine Pathways

Once cysteine enters a T cell, it takes on one of two critical roles that shape the immune response. One pathway utilizes the nutrient to produce glutathione, a potent antioxidant that regulates general cellular activity and prevents damage. Simultaneously, a second pathway directed by the enzyme NFS1 uses cysteine to supply sulfur for the creation of iron-sulfur clusters. These clusters are fundamental to the cell's structural growth and its ability to sustain a prolonged fight against cancer. The study, published in the journal Cell, highlights that these iron-sulfur clusters are the engine behind T cell expansion, allowing the immune response to scale up when a threat is detected.

Balancing Killing Power with Population Growth

The research team observed a striking trade-off when manipulating cysteine levels in laboratory models. When cysteine availability was restricted, the T cells actually became more aggressive and produced higher concentrations of signaling molecules designed to kill cancer. However, this heightened state of lethality came at a significant cost, as the cells lost their ability to divide and multiply. This suggests that while a "hungry" T cell might be a more potent individual killer, it cannot build the necessary army required to overcome a large or spreading tumor without a steady supply of cysteine-driven sulfur.